Expensify (EXFY) Cash & Equivalents (2020 - 2026)

Expensify has disclosed Cash & Equivalents across 7 years of filings, most recently posting $65.8 million for Q2 2026.

• In Q2 2026, Cash & Equivalents rose 8.66% year-over-year to $65.8 million; the TTM figure through Jun 2026 stood at $65.8 million (up 8.66% YoY), while the FY2025 annual figure was $63.1 million, up 29.34% from the prior year.
• Cash & Equivalents came in at $65.8 million for Q2 2026 at Expensify, down from $66.5 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $111.2 million in Q1 2023 to a low of $39.2 million in Q3 2024.
• Average Cash & Equivalents over 5 years is $73.9 million, with a median of $64.4 million recorded in 2025.
• Year-over-year, Cash & Equivalents soared 141.14% in 2022 and slumped 56.04% in 2024.
• Over 5 years, Cash & Equivalents stood at $103.8 million in 2022, then slumped by 54.22% to $47.5 million in 2023, then increased by 2.66% to $48.8 million in 2024, then gained by 29.34% to $63.1 million in 2025, then increased by 4.25% to $65.8 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $65.8 million in Q2 2026, $66.5 million in Q1 2026, and $63.1 million in Q4 2025.